Lypro BioSciences Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

Lypro BioSciences General Information

Description

Developer of drug-delivery technology. The company's nano-based drug technology is designed to increase the solubility and bio-availability of hydrophobic drugs and facilitates drug targeting to specific receptors, enabling drug manufacturing companies to receive next-generation drug delivery technologies.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • QB3 East Bay Innovation Center
  • 2929 Seventh Street, Suite 120
  • Berkeley, CA 94710
  • United States
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Acquirer
Corporate Office
  • QB3 East Bay Innovation Center
  • 2929 Seventh Street, Suite 120
  • Berkeley, CA 94710
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lypro BioSciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 08-Nov-2017 Completed Generating Revenue
5. Angel (individual) 07-Sep-2010 Completed Generating Revenue
4. Grant 01-Jan-2009 Completed Startup
3. Angel (individual) 09-Sep-2008 Completed Startup
2. Grant 01-Jan-2005 $927K Completed Startup
1. Accelerator/Incubator Completed Startup
To view Lypro BioSciences’s complete valuation and funding history, request access »

Lypro BioSciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Lypro BioSciences’s complete cap table history, request access »

Lypro BioSciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of drug-delivery technology. The company's nano-based drug technology is designed to increase the solubility a
Drug Delivery
Berkeley, CA

San Diego, CA
 

Hennigsdorf, Germany
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Lypro BioSciences Competitors (21)

One of Lypro BioSciences’s 21 competitors is BPS Bioscience, a Corporation company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BPS Bioscience Corporation San Diego, CA
Pantherna Therapeutics Formerly VC-backed Hennigsdorf, Germany
Sanescohealth Corporation Asheville, NC
PhaseBio Pharmaceuticals Formerly VC-backed Malvern, PA
Attune Pharmaceuticals Venture Capital-Backed New York, NY
You’re viewing 5 of 21 competitors. Get the full list »

Lypro BioSciences Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Life Science Angels Angel Group Minority
QB3 Accelerator/Incubator Minority
Xandex Ventures Corporate Venture Capital Minority
To view Lypro BioSciences’s complete investors history, request access »

Lypro BioSciences FAQs

  • When was Lypro BioSciences founded?

    Lypro BioSciences was founded in 2004.

  • Where is Lypro BioSciences headquartered?

    Lypro BioSciences is headquartered in Berkeley, CA.

  • What industry is Lypro BioSciences in?

    Lypro BioSciences’s primary industry is Drug Delivery.

  • Is Lypro BioSciences a private or public company?

    Lypro BioSciences is a Private company.

  • What is Lypro BioSciences’s current revenue?

    The current revenue for Lypro BioSciences is .

  • How much funding has Lypro BioSciences raised over time?

    Lypro BioSciences has raised $658K.

  • Who are Lypro BioSciences’s investors?

    Life Science Angels, QB3, and Xandex Ventures have invested in Lypro BioSciences.

  • Who are Lypro BioSciences’s competitors?

    BPS Bioscience, Pantherna Therapeutics, Sanescohealth, PhaseBio Pharmaceuticals, and Attune Pharmaceuticals are some of the 21 competitors of Lypro BioSciences.

  • When was Lypro BioSciences acquired?

    Lypro BioSciences was acquired on 08-Nov-2017.

  • Who acquired Lypro BioSciences?

    Lypro BioSciences was acquired by ABIONYX Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process